Evidence map›Paper›PMID 40473457›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2025

Cost-Effectiveness of [

Adrien Holzgreve, Lena M Unterrainer, Maximilian Tiling, Nabeel Mansour, Christine Spitzweg, Matthias Brendel, Jens Ricke, Marcus Unterrainer, Wolfgang G Kunz, Dirk Mehrens

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Assessing Value for Money in Theranostic Nuclear Medicine: A Systematic Review.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Pooled it
  2. Pooled it
  3. Prognostic value of the dual-tracer PET score (NETPET) in neuroendocrine tumors with [European journal of nuclear medicine and molecular imaging · 2026
    Article
  4. Inter-institutional variability in kidney dosimetry duringRadiological physics and technology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adrien HolzgreveDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany; Adrien.Holzgreve@med.lmu.de.
Lena M UnterrainerDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Maximilian TilingDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Nabeel MansourDepartment of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.
Christine SpitzwegDepartment of Internal Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.
Matthias BrendelDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Jens RickeDepartment of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.
Marcus UnterrainerDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Wolfgang G KunzDepartment of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.
Dirk MehrensDepartment of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recently published results of the NETTER-2 trial suggest the use of [

Indexed as

Intestinal NeoplasmsNeuroendocrine TumorsOctreotideOrganometallic CompoundsPancreatic NeoplasmsStomach NeoplasmsCost-Benefit AnalysisHumanslutetium Lu 177 dotatateOctreotideOrganometallic Compoundscost-effectiveness analysisGEPNETNETTER-2neuroendocrineoncologyradionuclide therapy

Identifiers

PMID40473457
PMCPMC12212402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.